Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Rivoglitazone Hcl
2. 60hqu68h8a
3. 299176-11-7
4. 299176-11-7 (hcl)
5. 2,4-thiazolidinedione, 5-((4-((6-methoxy-1-methyl-1h-benzimidazol-2-yl)methoxy)phenyl)methyl)-, Hydrochloride
6. 5-(4-((6-methoxy-1-methyl-1h-benzo[d]imidazol-2-yl)methoxy)benzyl)thiazolidine-2,4-dione Hydrochloride
7. Unii-60hqu68h8a
8. Cs-011 Hydrochloride
9. Schembl1592290
10. Chembl3526905
11. Ci-1037
12. Rivoglitazone Hydrochloride [who-dd]
13. Q27263228
14. 2,4-thiazolidinedione, 5-((4-((6-methoxy-1-methyl-1h-benzimidazol-2-yl)methoxy)phenyl)methyl)-, Hydrochloride (1:1)
15. 2,4-thiazolidinedione, 5-((4-((6-methoxy-1-methyl-1h-benzimidazol-2-yl)methoxy)phenyl)methyl)-, Monohydrochloride
16. 5-[[4-[(6-methoxy-1-methylbenzimidazol-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;hydrochloride
17. 5-[4-(6-methoxy-1-methyl-1-h-benzimidazol-2-ylmethoxy)benzyl]thiazolidin-2,4-dione Hydrochloride
18. 5-[4-(6-methoxy-1-methyl-1h-benzimidazol-2-ylmethoxy)benzyl]thiazolidine-2,4-dione Hydrochloride
19. 5-[4-(6-methoxy-1-methylbenzimidazol-2-ylmethoxy)benzyl]thiazolidin-2,4-dione Mono-hydrochloride
| Molecular Weight | 433.9 g/mol |
|---|---|
| Molecular Formula | C20H20ClN3O4S |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Exact Mass | 433.0863050 g/mol |
| Monoisotopic Mass | 433.0863050 g/mol |
| Topological Polar Surface Area | 108 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 584 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Rivoglitazone Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rivoglitazone Hydrochloride, including repackagers and relabelers. The FDA regulates Rivoglitazone Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rivoglitazone Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Rivoglitazone Hydrochloride supplier is an individual or a company that provides Rivoglitazone Hydrochloride active pharmaceutical ingredient (API) or Rivoglitazone Hydrochloride finished formulations upon request. The Rivoglitazone Hydrochloride suppliers may include Rivoglitazone Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Rivoglitazone Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Rivoglitazone Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Rivoglitazone Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Rivoglitazone Hydrochloride DMFs exist exist since differing nations have different regulations, such as Rivoglitazone Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Rivoglitazone Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Rivoglitazone Hydrochloride USDMF includes data on Rivoglitazone Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Rivoglitazone Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Rivoglitazone Hydrochloride suppliers with USDMF on PharmaCompass.
Rivoglitazone Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rivoglitazone Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rivoglitazone Hydrochloride GMP manufacturer or Rivoglitazone Hydrochloride GMP API supplier for your needs.
A Rivoglitazone Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Rivoglitazone Hydrochloride's compliance with Rivoglitazone Hydrochloride specifications and serves as a tool for batch-level quality control.
Rivoglitazone Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Rivoglitazone Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rivoglitazone Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Rivoglitazone Hydrochloride EP), Rivoglitazone Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rivoglitazone Hydrochloride USP).
LOOKING FOR A SUPPLIER?
